Somerset Therapeutics recalls

Somerset Therapeutics has 9 recalls on record with the FDA and USDA, the earliest in 2020 and the latest reported on 25 Mar 2026. 5 are still ongoing. 4 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls9since 2020

Last 12 months4reported

Class I00% of total

Ongoing5latest 25 Mar 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 1 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 3 0 0Feb 1 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 22%Class III 7 78%

Why somerset therapeutics is recalled

Potency & Assay889%
Foreign Material111%

Product types

Injectable & IV Drugs556%
Eye Drops444%

Brands

By year

2026111%
2025444%
2024111%
2020333%

Ongoing somerset therapeutics recalls

5 active

Reported	Class	Recall	Company	Reason	Where
25 Mar 2026Drug	CLASS II	Dexamethasone Sodium Phosphate Injection, USP, 100 mg recalledDexamethasone Sodium Phosphate	Somerset Therapeutics	Potency & Assay	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 10 mg/* (2mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Potency & Assay	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 200mg/*(10mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Potency & Assay	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 20 mg/*,(2 mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Potency & Assay	Nationwide
29 May 2024Drug	CLASS II	Haloperidol decanoate Injection 50mg/mL recalledHaloperidol Decanoate	Somerset Therapeutics	Foreign Material	Nationwide

All somerset therapeutics recalls, newest first

9 total

Reported	Class	Recall	Company	Reason	Where
25 Mar 2026Drug	CLASS II	Dexamethasone Sodium Phosphate Injection, USP, 100 mg recalledDexamethasone Sodium Phosphate	Somerset Therapeutics	Potency & Assay	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 10 mg/* (2mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Potency & Assay	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 200mg/*(10mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Potency & Assay	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 20 mg/*,(2 mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Potency & Assay	Nationwide
8 Jan 2025Drug	CLASS III	Atropine Sulfate Ophthalmic Solution recalled by Somerset TherapeuticsAtropine Sulfate	Somerset Therapeutics	Potency & Assay	Nationwide
29 May 2024Drug	CLASS II	Haloperidol decanoate Injection 50mg/mL recalledHaloperidol Decanoate	Somerset Therapeutics	Foreign Material	Nationwide
15 Jul 2020Drug	CLASS III	Brimonidine Tartrate Opthalmic Solution recalledBrimonidine Tartrate	Somerset Therapeutics	Potency & Assay	Nationwide
15 Jul 2020Drug	CLASS III	Brimonidine Tartrate Opthalmic Solution recalledBrimonidine Tartrate	Somerset Therapeutics	Potency & Assay	Nationwide
15 Jul 2020Drug	CLASS III	Brimonidine Tartrate Opthalmic Solution recalledBrimonidine Tartrate	Somerset Therapeutics	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.